
### [MONDO:0017716](http://purl.obolibrary.org/obo/MONDO_0017716)
**Label:** disorder of carnitine cycle and carnitine transport

**Subclasses:** [MONDO:0009705](http://purl.obolibrary.org/obo/MONDO_0009705) (carnitine palmitoyltransferase i deficiency), [MONDO:0010914](http://purl.obolibrary.org/obo/MONDO_0010914) (carnitine palmitoyl transferase II deficiency, severe infantile form), [MONDO:0008918](http://purl.obolibrary.org/obo/MONDO_0008918) (carnitine-acylcarnitine translocase deficiency), [MONDO:0008919](http://purl.obolibrary.org/obo/MONDO_0008919) (systemic primary carnitine deficiency disease), [MONDO:0012136](http://purl.obolibrary.org/obo/MONDO_0012136) (carnitine palmitoyl transferase II deficiency, neonatal form), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), [MONDO:0009704](http://purl.obolibrary.org/obo/MONDO_0009704) (carnitine palmitoyl transferase II deficiency, myopathic form), 

**Corr. equiv. classes:** [Orphanet:157](http://www.orpha.net/ORDO/Orphanet_157), [Orphanet:156](http://www.orpha.net/ORDO/Orphanet_156), [OMIM:608836](http://purl.obolibrary.org/obo/OMIM_608836), [OMIM:600649](http://purl.obolibrary.org/obo/OMIM_600649), [OMIM:255110](http://purl.obolibrary.org/obo/OMIM_255110), [OMIM:255120](http://purl.obolibrary.org/obo/OMIM_255120), [OMIM:212138](http://purl.obolibrary.org/obo/OMIM_212138), [Orphanet:228302](http://www.orpha.net/ORDO/Orphanet_228302), [OMIM:212140](http://purl.obolibrary.org/obo/OMIM_212140), [Orphanet:159](http://www.orpha.net/ORDO/Orphanet_159), [Orphanet:228305](http://www.orpha.net/ORDO/Orphanet_228305), [Orphanet:158](http://www.orpha.net/ORDO/Orphanet_158), [Orphanet:228308](http://www.orpha.net/ORDO/Orphanet_228308), 

**Class expressions from DL-Learner:**

- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0001638](http://purl.obolibrary.org/obo/HP_0001638) (Cardiomyopathy) and [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0001637](http://purl.obolibrary.org/obo/HP_0001637) (Abnormal myocardium morphology) and [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 60.11%
- [HP:0010967](http://purl.obolibrary.org/obo/HP_0010967) (Abnormality of carnitine metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 60.11%


